{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:29Z","timestamp":1792787789316,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","award":["Clinical\/Community Research Integration Support Program"],"award-info":[{"award-number":["Clinical\/Community Research Integration Support Program"]}],"id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Better Care","award":["Healthy Communities Funding Program"],"award-info":[{"award-number":["Healthy Communities Funding Program"]}]},{"DOI":"10.13039\/501100001202","name":"Gastroenterological Society of Australia","doi-asserted-by":"publisher","award":["Rose Amarant Grant to"],"award-info":[{"award-number":["Rose Amarant Grant to"]}],"id":[{"id":"10.13039\/501100001202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Research has indicated a lack of disease-specific reproductive knowledge among patients with Inflammatory Bowel Disease (IBD) and this has been associated with increased \u201cvoluntary childlessness\u201d. Furthermore, a lack of knowledge may contribute to inappropriate medication changes during or after pregnancy. Decision aids have been shown to support decision making in pregnancy as well as in multiple other chronic diseases. A published decision aid for pregnancy in IBD has not been identified, despite the benefit of pre-conception counselling and patient desire for a decision support tool. This study aimed to develop and test the feasibility of a decision aid encompassing reproductive decisions in the setting of IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The International Patient Decision Aid Standards were implemented in the development of the Pregnancy in IBD Decision Aid (PIDA). A multi-disciplinary steering committee was formed. Patient and clinician focus groups were conducted to explore themes of importance in the reproductive decision-making processes in IBD. A PIDA prototype was designed; patient interviews were conducted to obtain further insight into patient perspectives and to test the prototype for feasibility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Issues considered of importance to patients and clinicians encountering decisions regarding pregnancy in the setting of IBD included fertility, conception timing, inheritance, medications, infant health, impact of surgery, contraception, nutrition and breastfeeding. Emphasis was placed on the provision of preconception counselling early in the disease course. Decisions relating to conception and medications were chosen as the current focus of PIDA, however content inclusion was broad to support use across preconception, pregnancy and post-partum phases. Favourable and constructive user feedback was received.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The novel development of a decision aid for use in pregnancy and IBD was supported by initial user testing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-021-01853-y","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T08:03:39Z","timestamp":1627632219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Shared decision making in pregnancy in inflammatory bowel disease: design of a patient orientated decision aid"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-5329","authenticated-orcid":false,"given":"Astrid-Jane","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Chari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"De Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levinus A.","family":"Dieleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawnya","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Ismond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rshmi","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Fang-Hwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eytan","family":"Wine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"issue":"1","key":"1853_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ibd.21349","volume":"17","author":"EI Benchimol","year":"2011","unstructured":"Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17(1):423\u201339.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"1853_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1155\/2015\/715354","volume":"29","author":"VW Huang","year":"2015","unstructured":"Huang VW, Chang HJ, Kroeker KI, Goodman KJ, Hegadoren KM, Dieleman LA, et al. Does the level of reproductive knowledge specific to inflammatory bowel disease predict childlessness among women with inflammatory bowel disease? Can J Gastroenterol Hepatol. 2015;29(2):95\u2013103.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"1853_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ibd.20082","volume":"13","author":"SR Marri","year":"2007","unstructured":"Marri SR, Ahn C, Buchman AL. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(5):591\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1853_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.crohns.2010.12.012","volume":"5","author":"I Blumenstein","year":"2011","unstructured":"Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H, et al. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis. 2011;5(3):203\u201310.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"1853_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2036.2012.05130.x","volume":"36","author":"CP Selinger","year":"2012","unstructured":"Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G, et al. Patients\u2019 knowledge of pregnancy-related issues in inflammatory bowel disease and validation of a novel assessment tool ('CCPKnow\u2019). Aliment Pharmacol Ther. 2012;36(1):57\u201363.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1853_CR6","doi-asserted-by":"publisher","first-page":"S-149","DOI":"10.1016\/S0016-5085(12)60561-7","volume":"142","author":"UMC Mahadevan","year":"2012","unstructured":"Mahadevan UMC, Sandler RS, Kane SV, Dubinsky M, Lewis JD, Sandborn WJ, Sands BE. 865 PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy. Gastroenterology. 2012;142(5):S-149.","journal-title":"Gastroenterology"},{"issue":"8","key":"1853_CR7","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/ecco-jcc\/jjw052","volume":"10","author":"ZR Gallinger","year":"2016","unstructured":"Gallinger ZR, Rumman A, Nguyen GC. Perceptions and attitudes towards medication adherence during pregnancy in inflammatory bowel disease. J Crohns Colitis. 2016;10(8):892\u20137.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"1853_CR8","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/j.crohns.2012.09.010","volume":"7","author":"CP Selinger","year":"2013","unstructured":"Selinger CP, Eaden J, Selby W, Jones DB, Katelaris P, Chapman G, et al. Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis. 2013;7(6):e206\u201313.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"1853_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","volume":"150","author":"GC Nguyen","year":"2016","unstructured":"Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, et al. The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology. 2016;150(3):734-57.e1.","journal-title":"Gastroenterology"},{"issue":"4","key":"1853_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ajog.2019.02.027","volume":"220","author":"U Mahadevan","year":"2019","unstructured":"Mahadevan U, Robinson C, Bernasko N, Boland B, Chambers C, Dubinsky M, et al. Inflammatory bowel disease in pregnancy clinical care pathway: a report from the american gastroenterological association IBD parenthood project working group. Am J Obstet Gynecol. 2019;220(4):308\u201323.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1853_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/MIB.0000000000001102","volume":"23","author":"H Kammerlander","year":"2017","unstructured":"Kammerlander H, Nielsen J, Kjeldsen J, Knudsen T, Friedman S, Norgard B. The Effect of disease activity on birth outcomes in a Nationwide Cohort of women with moderate to severe inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(6):1011\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"1853_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1756-0500-6-210","volume":"6","author":"M Ujihara","year":"2013","unstructured":"Ujihara M, Ando T, Ishiguro K, Maeda O, Watanabe O, Hirayama Y, et al. Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis. BMC Res Notes. 2013;6:210.","journal-title":"BMC Res Notes"},{"issue":"6","key":"1853_CR13","first-page":"1091","volume":"20","author":"G Br\u00f6ms","year":"2014","unstructured":"Br\u00f6ms G, Granath F, Linder M, Stephansson O, Elmberg M, Kieler H. Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure. Inflamm Bowel Dis. 2014;20(6):1091\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"1853_CR14","unstructured":"Huang V. Thesis: reproductive knowledge specific to inflammatory bowel disease among women with IBD and physicians who treat women with IBD. 2014."},{"key":"1853_CR15","first-page":"1CD001431","volume":"1","author":"D Stacey","year":"2014","unstructured":"Stacey D, Legare F, Col NF, Bennett CL, Barry MJ, Eden KB, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:1CD001431.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"1853_CR16","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.socscimed.2012.01.041","volume":"74","author":"M Dugas","year":"2012","unstructured":"Dugas M, Shorten A, Dube E, Wassef M, Bujold E, Chaillet N. Decision aid tools to support women\u2019s decision making in pregnancy and birth: a systematic review and meta-analysis. Soc Sci Med. 2012;74(12):1968\u201378.","journal-title":"Soc Sci Med"},{"key":"1853_CR17","unstructured":"Patient Decision Aids Inventory. Ottawa Hospital Research Institute and University of Ottawa."},{"issue":"9","key":"1853_CR18","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.cgh.2016.03.018","volume":"14","author":"A de Lima","year":"2016","unstructured":"de Lima A, Zelinkova Z, Mulders AG, van der Woude CJ. Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol. 2016;14(9):1285-92.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1853_CR19","doi-asserted-by":"crossref","unstructured":"Sutton RT, Wierstra K, Huang VW. Knowledge translation dataset: an e-health intervention for pregnancy in inflammatory bowel disease. Data Brief. 2019;23:103647.","DOI":"10.1016\/j.dib.2018.12.085"},{"issue":"7","key":"1853_CR20","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/MIB.0000000000001110","volume":"23","author":"B Martinez","year":"2017","unstructured":"Martinez B, Dailey F, Almario CV, Keller MS, Desai M, Dupuy T, et al. Patient understanding of the risks and benefits of biologic therapies in inflammatory bowel disease: insights from a large-scale analysis of social media platforms. Inflamm Bowel Dis. 2017;23(7):1057\u201364.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1853_CR21","doi-asserted-by":"publisher","first-page":"e4705","DOI":"10.1371\/journal.pone.0004705","volume":"4","author":"G Elwyn","year":"2009","unstructured":"Elwyn G, O\u2019Connor AM, Bennett C, Newcombe RG, Politi M, Durand MA, et al. Assessing the quality of decision support technologies using the international patient decision aid standards instrument (IPDASi). PLoS ONE. 2009;4(3):e4705.","journal-title":"PLoS ONE"},{"issue":"5","key":"1853_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1177\/0272989X17697304","volume":"37","author":"A McGrath","year":"2017","unstructured":"McGrath A, Sharpe L, Lah S, Parratt K. Evaluation of a decision aid for women with epilepsy who are considering pregnancy: a randomized controlled trial. Med Decis Making. 2017;37(5):589\u201399.","journal-title":"Med Decis Making"},{"issue":"3","key":"1853_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0738-3991(98)00026-3","volume":"33","author":"AM O'Connor","year":"1998","unstructured":"O\u2019Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998;33(3):267\u201379.","journal-title":"Patient Educ Couns"},{"issue":"3","key":"1853_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/0272989X9801800307","volume":"18","author":"AM O'Connor","year":"1998","unstructured":"O\u2019Connor AM, Tugwell P, Wells GA, Elmslie T, Jolly E, Hollingworth G, et al. Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making. 1998;18(3):295\u2013303.","journal-title":"Med Decis Making"},{"issue":"5","key":"1853_CR25","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/1352458507086103","volume":"14","author":"M Prunty","year":"2008","unstructured":"Prunty M, Sharpe L, Butow P, Fulcher G. The motherhood choice: themes arising in the decision-making process for women with multiple sclerosis. Mult Scler. 2008;14(5):701\u20134.","journal-title":"Mult Scler"},{"issue":"2","key":"1853_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/msc.1031","volume":"11","author":"T Meade","year":"2013","unstructured":"Meade T, Sharpe L, Hallab L, Aspanell D, Manolios N. Navigating motherhood choices in the context of rheumatoid arthritis: women\u2019s stories. Musculoskeletal Care. 2013;11(2):73\u201382.","journal-title":"Musculoskeletal Care"},{"key":"1853_CR27","series-title":"American Psychological Association","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1037\/13620-004","volume-title":"APA handbook of research methods in psychology, vol 2 research designs: quantitative, qualitative, neuropsychological, and biological","author":"V Braun","year":"2012","unstructured":"Braun V, Clarke V. Thematic analysis. In: Cooper H, Long DL, Panter AT, Rindskopf D, Sher KJ, editors. APA handbook of research methods in psychology, vol 2 research designs: quantitative, qualitative, neuropsychological, and biological, vol. 2. American Psychological Association. DC: Washington; 2012. p. 57\u201371."},{"issue":"5","key":"1853_CR28","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/apt.14487","volume":"47","author":"P Wils","year":"2018","unstructured":"Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, et al. Long-term efficacy and safety of ustekinumab in 122 refractory Crohn\u2019s disease patients: a multicentre experience. Aliment Pharmacol Ther. 2018;47(5):588\u201395.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1853_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12876-017-0633-6","volume":"17","author":"C Venturin","year":"2017","unstructured":"Venturin C, Nancey S, Danion P, Uzzan M, Chauvenet M, Bergoin C, et al. Fetal death in utero and miscarriage in a patient with Crohn\u2019s disease under therapy with ustekinumab: case-report and review of the literature. BMC Gastroenterol. 2017;17(1):80.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"1853_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/ecco-jcc\/jjx123","volume":"12","author":"C Thomas","year":"2018","unstructured":"Thomas C, Monteil-Ganiere C, Mirallie S, Hemont C, Dert C, Leger A, et al. A severe neonatal lymphopenia associated with administration of azathioprine to the mother in a context of Crohn\u2019s disease. J Crohns Colitis. 2018;12(2):258\u201361.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"1853_CR31","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/ecco-jcc\/jjx141","volume":"12","author":"CR Rowan","year":"2018","unstructured":"Rowan CR, Cullen G, Mulcahy HE, Keegan D, Byrne K, Murphy DJ, et al. Ustekinumab drug levels in maternal and cord blood in a woman with Crohn\u2019s disease treated until 33 weeks of gestation. J Crohns Colitis. 2018;12(3):376\u20138.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"1853_CR32","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1007\/s10620-016-4353-5","volume":"62","author":"RK Padhan","year":"2017","unstructured":"Padhan RK, Kedia S, Garg SK, Bopanna S, Mouli VP, Dhingra R, et al. Long-term disease course and pregnancy outcomes in women with inflammatory bowel disease: an Indian cohort study. Dig Dis Sci. 2017;62(8):2054\u201362.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1853_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/ibd\/izx006","volume":"24","author":"T Myklebust-Hansen","year":"2017","unstructured":"Myklebust-Hansen T, Aamodt G, Haugen M, Brantsaeter AL, Vatn MH, Bengtson MB. Dietary patterns in women with inflammatory bowel disease and risk of adverse pregnancy outcomes: results from The Norwegian Mother and Child Cohort Study (MoBa). Inflamm Bowel Dis. 2017;24(1):12\u201324.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"1853_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/1751-2980.12539","volume":"18","author":"L Martelli","year":"2017","unstructured":"Martelli L, Lopez A, Strobel S, Danese S, Roblin X, Baumann C, et al. Adherence to infliximab therapy in inflammatory bowel disease patients in a real-life setting. J Dig Dis. 2017;18(10):566\u201373.","journal-title":"J Dig Dis"},{"issue":"6","key":"1853_CR35","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/ecco-jcc\/jjy030","volume":"12","author":"S Lee","year":"2018","unstructured":"Lee S, Metcalfe A, Raman M, Leung Y, Aghajafari F, Letourneau N, et al. Pregnant women with inflammatory bowel disease are at increased risk of vitamin D insufficiency: a cross-sectional study. J Crohns Colitis. 2018;12(6):702\u20139.","journal-title":"J Crohns Colitis"},{"issue":"1","key":"1853_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1053\/j.gastro.2016.12.054","volume":"153","author":"SL Kanis","year":"2017","unstructured":"Kanis SL, van der Woude CJ. Endoscopy for inflammatory bowel disease during pregnancy: only when there is a strong indication. Gastroenterology. 2017;153(1):330\u20131.","journal-title":"Gastroenterology"},{"issue":"8","key":"1853_CR37","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cgh.2017.02.041","volume":"15","author":"SL Kanis","year":"2017","unstructured":"Kanis SL, de Lima-Karagiannis A, de Boer NKH, van der Woude CJ. Use of thiopurines during conception and pregnancy is not associated with adverse pregnancy outcomes or health of infants at one year in a prospective study. Clin Gastroenterol Hepatol. 2017;15(8):1232-41 e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"1853_CR38","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1097\/MIB.0000000000001234","volume":"23","author":"H Kammerlander","year":"2017","unstructured":"Kammerlander H, Nielsen J, Knudsen T, Kjeldsen J, Friedman S, Norgard BM. Anti-TNF-alpha use during the third trimester of pregnancy in women with moderate-severe inflammatory bowel disease and the risk of preterm birth and low birth weight. Inflamm Bowel Dis. 2017;23(11):1916\u201323.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"1853_CR39","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/MIB.0000000000001102","volume":"23","author":"H Kammerlander","year":"2017","unstructured":"Kammerlander H, Nielsen J, Kjeldsen J, Knudsen T, Friedman S, N\u00f8rg\u00e5rd B. The effect of disease activity on birth outcomes in a nationwide cohort of women with moderate to severe inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(6):1011\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1853_CR40","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/ibd\/izx055","volume":"24","author":"H Kammerlander","year":"2018","unstructured":"Kammerlander H, Nielsen J, Kjeldsen J, Knudsen T, Gradel KO, Friedman S, et al. Fecal calprotectin during pregnancy in women with moderate-severe inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(4):839\u201348.","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"1853_CR41","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1136\/gutjnl-2016-313444","volume":"66","author":"M Julsgaard","year":"2017","unstructured":"Julsgaard M, Kjeldsen J, Baumgart DC. Vedolizumab safety in pregnancy and newborn outcomes. Gut. 2017;66(10):1866\u20137.","journal-title":"Gut"},{"issue":"7","key":"1853_CR42","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/MIB.0000000000001136","volume":"23","author":"M Julsgaard","year":"2017","unstructured":"Julsgaard M, Hvas CL, Gearry RB, Vestergaard T, Fallingborg J, Svenningsen L, et al. Fecal calprotectin is not affected by pregnancy: clinical implications for the management of pregnant patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(7):1240\u20136.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"1853_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2169\/internalmedicine.8550-16","volume":"57","author":"A Ito","year":"2018","unstructured":"Ito A, Iizuka B, Omori T, Nakamura S, Tokushige K. Relationship between the clinical course of ulcerative colitis during pregnancy and the outcomes of pregnancy: a retrospective evaluation. Intern Med. 2018;57(2):159\u201364.","journal-title":"Intern Med"},{"issue":"7","key":"1853_CR44","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/MEG.0000000000001117","volume":"30","author":"J Hoekstra","year":"2018","unstructured":"Hoekstra J, van Roon AHC, Bekkering FC, van Tilburg AJP, West RL. Decision making and outcome of pregnancies in female patients with inflammatory bowel disease: findings from a community-based practice. Eur J Gastroenterol Hepatol. 2018;30(7):704\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"45","key":"1853_CR45","doi-asserted-by":"publisher","first-page":"8082","DOI":"10.3748\/wjg.v23.i45.8082","volume":"23","author":"B Gonzalez-Suarez","year":"2017","unstructured":"Gonzalez-Suarez B, Sengupta S, Moss AC. Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: a meta-analysis. World J Gastroenterol. 2017;23(45):8082\u20139.","journal-title":"World J Gastroenterol"},{"key":"1853_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1179670717746333","volume":"8","author":"K Fujioka","year":"2017","unstructured":"Fujioka K, Fukushima S, Nishida K, Iijima K, Morioka I. Intraventricular hemorrhage due to coagulopathy after vitamin K administration in a preterm infant with maternal crohn disease. Jpn Clin Med. 2017;8:1\u20134.","journal-title":"Jpn Clin Med"},{"issue":"8","key":"1853_CR47","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s10620-017-4635-6","volume":"62","author":"S Friedman","year":"2017","unstructured":"Friedman S. Gestational weight gain: a new factor influencing pregnancy outcomes in women with inflammatory bowel disease. Dig Dis Sci. 2017;62(8):2070\u20131.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1853_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cgh.2017.06.054","volume":"16","author":"PS de Silva","year":"2018","unstructured":"de Silva PS, Hansen HH, Wehberg S, Friedman S, Norgard BM. Risk of ectopic pregnancy in women with inflammatory bowel disease: a 22-year nationwide cohort study. Clin Gastroenterol Hepatol. 2018;16(1):83-9 e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1853_CR49","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3389\/fimmu.2017.01123","volume":"8","author":"A Esteve-Sole","year":"2017","unstructured":"Esteve-Sole A, Deya-Martinez A, Teixido I, Ricart E, Gompertz M, Torradeflot M, et al. Immunological changes in blood of newborns exposed to anti-TNF-alpha during pregnancy. Front Immunol. 2017;8:1123.","journal-title":"Front Immunol"},{"issue":"6","key":"1853_CR50","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.gie.2017.05.043","volume":"86","author":"R Di Mitri","year":"2017","unstructured":"Di Mitri R, Mocciaro F, Maiorana A, Alio W, Orlando A. Endoscopic rescue treatment in a pregnant ulcerative colitis patient with a severe colonic stricture: a conservative approach to bring the pregnancy to term. Gastrointest Endosc. 2017;86(6):1183\u20135.","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"1853_CR51","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/art.40508","volume":"70","author":"MEB Clowse","year":"2018","unstructured":"Clowse MEB, Scheuerle AE, Chambers C, Afzali A, Kimball AB, Cush JJ, et al. Pregnancy outcomes after exposure to certolizumab pegol: updated results from a pharmacovigilance safety database. Arthritis Rheumatol. 2018;70(9):1399\u2013407.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1853_CR52","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/ajg.2017.501","volume":"113","author":"M Chaparro","year":"2018","unstructured":"Chaparro M, Verreth A, Lobaton T, Gravito-Soares E, Julsgaard M, Savarino E, et al. Long-term safety of in utero exposure to anti-TNFalpha drugs for the treatment of inflammatory bowel disease: results from the multicenter European TEDDY study. Am J Gastroenterol. 2018;113(3):396\u2013403.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"1853_CR53","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10620-017-4547-5","volume":"62","author":"MB Bengtson","year":"2017","unstructured":"Bengtson MB, Martin CF, Aamodt G, Vatn MH, Mahadevan U. Inadequate gestational weight gain predicts adverse pregnancy outcomes in mothers with inflammatory bowel disease: results from a prospective US pregnancy cohort. Dig Dis Sci. 2017;62(8):2063\u20139.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"1853_CR54","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1097\/MIB.0000000000001123","volume":"23","author":"MB Bengtson","year":"2017","unstructured":"Bengtson MB, Aamodt G, Mahadevan U, Vatn MH. Inadequate gestational weight gain, the hidden link between maternal IBD and adverse pregnancy outcomes: results from the norwegian mother and child cohort study. Inflamm Bowel Dis. 2017;23(7):1225\u201333.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"1853_CR55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","volume":"16","author":"DB Beaulieu","year":"2018","unstructured":"Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U. Use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines. Clin Gastroenterol Hepatol. 2018;16(1):99\u2013105.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"1853_CR56","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","volume":"76","author":"ME Clowse","year":"2017","unstructured":"Clowse ME, F\u00f6rger F, Hwang C, Thorp J, Dolhain RJ, van Tubergen A, et al. Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. Ann Rheum Dis. 2017;76(11):1890\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1853_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1037\/h0057532","volume":"32","author":"R Flesch","year":"1948","unstructured":"Flesch R. A new readability yardstick. J Appl Psychol. 1948;32(3):221\u201333.","journal-title":"J Appl Psychol"},{"key":"1853_CR58","doi-asserted-by":"crossref","unstructured":"Kanazaki R, Smith B, Girgis A, Descallar J, Connor S. Survey of barriers to adherence to international inflammatory bowel disease guidelines: does gastroenterologists\u2019 confidence translate to high adherence?. Int Med J. 2021.","DOI":"10.1111\/imj.15299"},{"issue":"5","key":"1853_CR59","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/bmjqs-2017-006986","volume":"27","author":"KR Sepucha","year":"2018","unstructured":"Sepucha KR, Abhyankar P, Hoffman AS, Bekker HL, LeBlanc A, Levin CA, et al. Standards for universal reporting of patient decision aid evaluation studies: the development of SUNDAE checklist. BMJ Qual Saf. 2018;27(5):380\u20138.","journal-title":"BMJ Qual Saf"},{"issue":"7565","key":"1853_CR60","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/bmj.38926.629329.AE","volume":"333","author":"G Elwyn","year":"2006","unstructured":"Elwyn G, O\u2019Connor A, Stacey D, Volk R, Edwards A, Coulter A, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333(7565):417.","journal-title":"BMJ"},{"issue":"1","key":"1853_CR61","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.2196\/resprot.4037","volume":"4","author":"D Kingston","year":"2015","unstructured":"Kingston D, Janes-Kelley S, Tyrrell J, Clark L, Hamza D, Holmes P, et al. An integrated web-based mental health intervention of assessment-referral-care to reduce stress, anxiety, and depression in hospitalized pregnant women with medically high-risk pregnancies: a feasibility study protocol of hospital-based implementation. JMIR Res Protoc. 2015;4(1):e9.","journal-title":"JMIR Res Protoc."}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-01853-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T08:07:25Z","timestamp":1627632445000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01853-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01853-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-131067\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"assertion":[{"value":"6 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study had ethics approval from the associated institutions: UNSW (Human Research Ethics Committee number: 2019\/ETH00254); UBC (Research Ethics Board Number: H17-02354); U of T (Research Ethics Board Number: 18-0215-E); U of A (Pro00071492 Decision Making for Women with IBD). Informed written consent was obtained from participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"AJW: Honoraria received from Takeda, Janssen, Pfizer and Abbvie and Honoraria and grant support from Ferring. NK: Grant support received from Janssen and educational support from Ferring. RC, KPI, RK, DK, KO, DCS, FFT: No COI. SJC: Honoraria for Advisory Board participation, speaker fees, educational support and\/or research support from Abbvie, BMS, Celltrion, Chiesi, DrFalk, Ferring, Fresenius Kabi, Gilead, Janssen, MSD, Novartis, Pfizer, Takeda. MADV: Canada Research Chair in Medication Adherence, Utilization, and Outcomes. LAD: Honoraria received from Janssen, Abbvie and Pfizer. TH: Advisory boards of Takeda Canada and Johnson Canada and research funding from Pfizer Canada. EW: Honoraria received from Abbvie, Janssen, Nestle. YPL: Honoraria for Advisory Board participation and speaker fees from Janssen, Abbvie, Takeda, Pfizer and Merck. VWH: Honoraria received from Abbvie, Ferring, Janssen, Merck, Pfizer, Roche, Takeda.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}